Skip to main content

2024 PharmSci 360 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Rakesh Dachineni, Ph.D.

Scientist
Teva Branded Pharmaceutical Products R&D, Inc.

Poster(s):

(M1030-05-25) Impact of Using 2-Hydroxypropyl-b-cyclodextrin (HPbCD) as an Excipient in Biologic Formulations on Solution Properties and Compatibility

Monday, October 21, 2024
10:30 AM – 11:30 AM MT